TalkMed Group Limited (SGX:5G3)

Market Cap	585.32M
Revenue (ttm)	78.18M
Net Income (ttm)	43.79M
Shares Out	1.33B
EPS (ttm)	0.03
PE Ratio	13.46
Forward PE	n/a
Dividend	0.04 (8.18%)
Ex-Dividend Date	n/a

Volume	217,100
Average Volume	95,595
Open	0.4400
Previous Close	0.4350
Day's Range	0.4350 - 0.4450
52-Week Range	0.3800 - 0.5000
Beta	0.02
RSI	43.65
Earnings Date	Apr 24, 2025

About TalkMed Group

TalkMed Group Limited, an investment holding company, provides medical oncology, stem cell transplants, palliative care, and other related services in Singapore, China, Hong Kong, Vietnam, India, New Zealand, Australia, and the United States. It operates through two segments: Oncology Services; and Cellular and Gene Therapy Related Products and Services. The company offers medical oncology services in the areas of breast, colon, lung, liver, biliary and pancreatic, gastro-intestinal, head and neck, genitourinary and gynaecological, and haematol...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1997
• Employees: 232
• Stock Exchange: Singapore Exchange
• Ticker Symbol: 5G3

Financial Performance

In 2024, TalkMed Group's revenue was 78.18 million, a decrease of -6.70% compared to the previous year's 83.79 million. Earnings were 43.79 million, an increase of 36.10%.